Events Archives - Page 25 of 128

3 minute read

OmniAb Highlights OmnidAb Launch And Its Expanding Drug Discovery Platform At Today’s Research & Technology Virtual Event

November 9, 8:10 PM

Webcast and event slides available hereOmniAb, Inc. (NASDAQ:OABI) held its first Research & Technology virtual event earlier today, during which members of the management team reviewed the Company's technology

OABI

1 minute read

Crypto Compliance: What’s The Impact of Regulation?

By Tanzeel Akhtar

November 9, 7:41 PM

Regulators have been slow to introduce legislation around crypto assets for over a decade due to the cryptocurrencies being built on decentralized technology — but this is changing.

BTC

4 minute read

Vor Bio Presents Data Update On Trem-cel At HSCT Conference; Primary Neutrophil Engraftment Of Trem-cel Achieved In All Seven Patients Treated To Date

By Benzinga Newsdesk

November 9, 5:49 PM

Primary neutrophil engraftment of trem-cel achieved in all seven patients treated to date All three patients receiving multiple Mylotarg™ doses exhibited hematologic protection, further validating Vor

VOR

2 minute read

VanEck’s Matthew Sigel To Share The Latest Crypto Outlook At Benzinga’s Future Of Digital Assets Conference

By Stjepan Kalinic

November 9, 1:44 PM

Matthew Sigel helps formulate VanEck’s digital asset strategies and sits on the investment committee of several of the firm’s private funds. His research involves Bitcoin, smart contract platforms and emerging market crypto and is regularly featured in top media outlets.

SOL

5 minute read

Adam Nash: Why You Should Always Donate Stock Instead Of Cash

By Adam Nash

November 9, 12:59 PM

Adam Nash, co-founder & CEO of Daffy.org will be speaking at the upcoming Benzinga Fintech Deal Day & Awards. Mark Nov. 13 on your calendar for the must-attend gathering in the fintech industry!

AAPL

2 minute read

Medicenna To Present 4 Year Follow-Up Phase 2b Bizaxofusp Survival Data In Recurrent Glioblastoma At The Society For Neuro-Oncology 2023 Annual Meeting

By Benzinga Newsdesk

November 9, 10:15 AM

Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX:MDNA, OTC:MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines, today announced that a poster presentation and an oral

MDNA

2 minute read

Events
News

AgEagle To Showcase Its Drone Innovations At Renowned Milipol Homeland Security Event And Modern Warfare Week

By Benzinga Newsdesk

November 9, 9:30 AM

AgEagle Aerials Systems Inc. (NYSE:UAVS) ("AgEagle" or the "Company"), an industry-leading provider of full stack flight hardware, sensors and software for commercial and government use, announces that the Company will

UAVS

3 minute read

Biomea Fusion To Present New Data From Ongoing Phase II Study Of BMF-219 In Patients With Type 2 Diabetes At The World Congress Insulin Resistance, Diabetes & Cardiovascular Disease

By Benzinga Newsdesk

November 8, 6:21 PM

An abstract, "BMF-219: A novel therapeutic agent to reestablish functional beta cells and provide long-term glycemic control" will be presented during the WCIRDC meeting held in Los Angeles, December 7-9,

BMEA

2 minute read

The Hidden Risks of the Internet: Insights by Filecoin Executive, ‘We’re At This Moment Where People Recognize the Value of Having A Greater Ownership Stake In Their Data’

By Jose Rodrigo Safdiye

November 8, 6:02 PM

"The Internet's fragility is more obvious than we think," said Rachel Green Horn, the head of Marketing and Communications at Filecoin (CRYPTO: FIL) Foundation, during a panel discussion at

$FIL

6 minute read

Aurinia Presents Breadth Of Data From AURORA Clinical Program Underscoring Value Of LUPKYNI For Patients With Lupus Nephritis At ACR 2023

By Benzinga Newsdesk

November 7, 11:35 AM

A propensity analysis of AURORA 1 suggested that initial therapy with LUPKYNIS® plus standard of care improved safety and demonstrated earlier reductions in proteinuria when compared to a conventional regimen

AUPH